{{Rsnum
|rsid=12137855
|Chromosome=1
|position=219275036
|Orientation=plus
|GMAF=0.1648
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 63.7 | 31.9 | 4.4
| HCB | 88.3 | 11.7 | 0.0
| JPT | 87.5 | 11.6 | 0.9
| YRI | 69.4 | 24.5 | 6.1
| ASW | 68.4 | 28.1 | 3.5
| CHB | 88.3 | 11.7 | 0.0
| CHD | 86.2 | 13.8 | 0.0
| GIH | 66.3 | 30.7 | 3.0
| LWK | 58.2 | 32.7 | 9.1
| MEX | 74.1 | 25.9 | 0.0
| MKK | 51.6 | 40.0 | 8.4
| TSI | 60.8 | 39.2 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24477042
|Title=Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals
}}

{{PMID Auto
|PMID=21423719
|Title=Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}